Congress Must Protect Patient Safety and Promote Innovation in Considering Follow-on Biologics Pathway
BIO Submits Letter to Congress Detailing Concerns Regarding Clinton-Schumer Legislation Urges Congress to Consider Any Action on Follow-Ons Independent of PDUFA